Cristina Ciocca

Title: Cristina Ciocca: Innovator in Pharmaceutical Formulations

Introduction

Cristina Ciocca is a notable inventor based in Motta Visconti, Italy. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of platinum derivative solutions for antitumor therapy. With a total of 2 patents, her work is paving the way for advancements in cancer treatment.

Latest Patents

Cristina's latest patents include innovative formulations that utilize oxaliplatin, a chemotherapy drug. The first patent describes novel stable solution formulations comprising oxaliplatin alone or in combination with irinotecan (CPT-11), along with an effective stabilizing amount of lactic acid and/or a pharmaceutically acceptable salt thereof, and a suitable carrier. This invention also encompasses a method for manufacturing these formulations, which are ready for administration and can be used in antitumor therapy. The second patent similarly focuses on stable solution formulations of oxaliplatin, emphasizing the importance of lactic acid and its salts in enhancing the stability and efficacy of the drug.

Career Highlights

Cristina Ciocca is currently associated with Pharmacia Italia S.p.a., where she continues to innovate in the pharmaceutical sector. Her expertise in developing stable formulations has positioned her as a key player in the industry, contributing to improved therapeutic options for patients.

Collaborations

Cristina collaborates with talented professionals such as Sara Lauria and Alessandro Martini, who contribute to her research and development efforts. Their teamwork enhances the innovative processes within their projects.

Conclusion

Cristina Ciocca's work in pharmaceutical formulations exemplifies the impact of innovation in healthcare. Her patents not only reflect her expertise but also hold the potential to improve cancer treatment outcomes.